Connect with us


You are what you eat

When it comes to CBD, most people think of balms and oils, but snacks containing the active ingredients are growing in popularity.



When it comes to CBD, most people think of balms and oils, but snacks containing the active ingredients are growing in popularity. Cannabis Health finds out more.

Britain is a nation of snackers. With 66 per cent of the population snacking at least once a day, the appetite for new products is growing all the time.

And one of the largest growth markets is in so-called ‘healthy’ snacks, although some may feel this is somewhat of an oxymoron.

Nevertheless, with the way we eat changing – increasingly busy lifestyles mean more and more people are eating on the go – consumers are looking to get more out of their snacks than just something to eat.

Kale chips, rice cakes, protein bars – these have all risen in popularity over the past few years, as snackers look for something that offers them something in the way of nutritional value.

Research has found that 44 per cent of adults see snacks as a good way to boost their nutritional intake – and with only half of Britons getting their recommended five a day, healthy snacks play a growing role in helping the nation make healthier choices.

With a health-conscious audience keen to try new things and a variety of innovative – and tasty – foodstuffs available, it’s fair to say that CBD snacks have definitely found their time to shine.

Epicurium is a health food distributor based in Consett, County Durham, which has been selling innovative, on-trend snacking products since 2011.

Always keen to offer retailers and consumers something new, the site has been stocking a range of CBD products for nearly a year now.

Customer engagement manager Michael Ratheram explains: “Research has found that about ten per cent of UK adults have tried a CBD snack, and four in ten Millennials would be willing to try CBD in a soft drink, so the demand is obviously there.

“We sell two CBD-infused drinks brands – Leaf Life and Drink420, along with a baked oat bar called Nooro – all are very new to market as you’d expect.

“The market is still very much at the early adopter stage; a year ago, CBD may not have even been on shoppers’ or retailers’ radars – some will have likely have never even heard of it!

“Having said that, the products we stock have been remarkably popular from the get-go – with about 10 per cent of our customers stocking the range.”

As those familiar with CBD will know, one of its principal uses as a health food supplement is for stress and pain relief, and this is as true for snacks as it is for the more traditional oils and balms.

As Epicurium trading manager James Christie explains: “One of the reasons for the popularity of CBD drinks and snacks is the health benefit. People are using these products to relieve physical and mental pain, such as stress, anxiety and insomnia, and so they’re more than happy to swap a sugary, less functional drink for one that satisfies their thirst and gives them something back.”

Consumers’ growing sense of adventure and desire to be different also plays a part, with buyers always looking for the next big thing.

“Today’s shoppers want more than a standard can of pop and chocolate bar,” says Michael. “Instead, they are open to more adventurous ingredients and healthier versions of sugar laden or more mundane options.

“They’re paying closer attention than ever to ingredients and health benefits, demanding more exciting flavours whilst not compromising on taste, and this is all opening up fresh opportunities for growth in the independent sector.”

Of course, CBD is not without its issues – the comparison with cannabis still endures and many consumers are wary of infused products, with ongoing legislative issues adding to the confusion.

Michael says: “I think above all else, there’s still confusion whether or not it’s classed as an age-restricted purchase for retailers to offer, as well as some concerns around legalities due to a lack of understanding.”

James adds: “We find a lot of customers are concerned over certification and still associate the negativity of cannabis with CBD. However, with the novel food classification coming in in March 2021, we will finally see the grey areas removed, with 74 per cent of people supporting the guidance on the subject.”

Despite the concerns, demand for CBD products continues to grow, particularly among younger consumers and those more attuned with what’s on trend – a fact borne out by the types of retailers buying Epicurium’s stock.

Michael said: Our typical customers are likely to be the early adopters and forward thinking retailers –university campus stores, convenience stores in city centre/transient locations, online snack subscription retailers – it’s those agile businesses who want to keep ahead of the curve.

“Universities are always very eager early adopters of new and innovative products, as it’s the perfect fit for their consumer base; it’s new, it’s in the limelight and with Gen-z and Millennials leading the charge in healthy snacking, it’s the perfect item to stock.”

While CBD oils and balms are still popular, particularly for those looking for relief from physical pain, an increased focus on nutrition, combined with a stressed and anxious population in need of new ways to relax, mean CBD snacks may have found themselves in the right place at the right time.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Enterprise and education – a CBD story



Mike Peates, founder of Medivita

From selling personalised chocolates to CBD balms and edibles, Medivita founder Mike Peates tells Cannabis Health how his latest venture was inspired by his chronic pain.

As a salesman, Mike Peates was used to spending hour after hour in his car, travelling around 25,000 miles a year.

And when he stopped to set up his own business, making and selling personalised chocolates with company logos printed on them, he found the problem only increased, as he spent up to five hours a day standing.

“The final quarter of the year, from October through to January, would be my busiest time, and I’d be spending most of my working day on my feet,” he says.

“I already had chronic back pain from my years spent in cars, and, over the five years, I had the chocolate business, it just got worse and worse.

“It got to the point where I’d come home from work and I’d be lying on the floor for about an hour to try to straighten my back out. And then the next morning, it’d be very much a question of, ‘okay, how do I move to even just get out of bed?’.

“The pain was so bad; it was a question of doing every action in stages, like pushing a chair back, then standing up, then managing to walk and get out of the house and do a full day’s work. And I managed all this for a couple of years.”

It was a chance remark on a Facebook post that prompted Mike to look into alternative remedies for his pain – despite being a self-confessed sceptic.

He said: “I saw a post from an old school friend about a health food shop in Lincolnshire that was moving to larger premises in order to stock CBD products.

“I happened to be off work for a few days at the time and so I ended up in a bit of a Google wormhole, researching what CBD is and what it could be used for.

“And to be honest, I was the biggest cynic ever in regards to what I’d call ‘herbal medicine’ in inverted commas, I always thought it was just one of these fads people are joining up to more and more.”

However, Mike’s curiosity was piqued, and, having thoroughly researched what would be the best product to start with, he decided to give it a try.

“I must admit, the price was a little off-putting, and I was concerned it was quite an expensive way to try it and for it not to work, but then I thought, why not?

“So, I ordered some; it arrived the next day, and I told myself to be open-minded and give it a go.

“Well, I took a couple of drops and within 20 minutes, I could feel a huge difference. I mean, it wasn’t just like taking the edge off the pain; the pain almost disappeared. And that was just my first dose!”

Mike continued using the CBD – “it was just the case that it really, really worked for me” – while working on a project at a tech incubator hub in Basingstoke, where he lives. In need of a little extra cash, he began reselling the CBD he was buying online to family and friends, which was the catalyst for his latest venture.

He explains: “I got talking to my mentor at the tech incubator about it and said, ‘look, I’ve been doing this, I’ve sold about £700 in the first few weeks without even doing any marketing’.

“Now, he knows what he’s doing – he founded two businesses which he exited very successfully – and he suggested we sit down over coffee and have a chat about it all.

“So, one Saturday morning, we have that meeting, we came out and we decided we were going to set up a CBD business together.

“It wasn’t a quick process – it took most of the summer to actually choose a name and choose the branding – but by September we were ready and Medivita was born.”

Mike admits it took a while to get established, and both he and his business partner were keen to ensure they got the right product, which is where his own experiences proved invaluable.

“Because I’d taken CBD before, I knew what worked, but we went through about six or seven different samples of CBD oil before we before we decided on the one we now sell,” he says.

“We knew we wanted full spectrum (a variety typically high in CBD, with only trace amounts of minor cannabinoids, and very low in THC, the main psychoactive compound in marijuana). We knew we wanted it to be full plant and we knew that it actually had to work when I tested it – it actually had to deliver some benefit from taking it.

“To be honest, there were a few that I had which left me just feeling, ‘well, it’s okay, but it’s not great, it’s not just quite hitting the spot’. And supply wise, even a year ago it was actually quite difficult to find people wholesaling and white labelling (the practice of putting a different brand on a product than that of the original producer). I think in 12 months that has really, really changed, and it’s now a lot easier to find wholesalers and white labels.”

Since then, the business has gone from strength to strength, but Mike is keen to stress that Medivita is not simply about selling a product – he works with a number of groups to help them understand the potential benefits of CBD.

He explains: “We sell online and we sell quite a lot locally, but we also do a lot of work in the local area with the Basingstoke Disability Forum, doing talks at their events, to educate people.

“That’s why we closely follow the likes of Professor Mike Barnes and Dr Dani Gordon with what they do. It helps to keep ourselves up to date with what’s happening, but it’s also useful to have that knowledge when people ask us, not simply about our product, but about CBD levels and THC levels and the endocannabinoid system, and so forth.

“We want to become people who consumers can trust, through knowing what we’re doing so that we can give best information and let people make a really informed choice, rather than just buying the cheapest bottle on the shelf.”

Mike is aware of the cynicism surrounding the use of CBD as a food supplement, but, as a former sceptic himself, he is able to relate to a level of mistrust.

“When we’re talking to disability forums and the like, we are met with quite a bit of resistance – which I understand,” he says.

“We do find that because a lot of the people we speak to are on a full regime of medication, they can be quite reluctant to try something new. I remember one lady in particular from when we attended the Chronic Pain Forum, who we’ve just had a testimonial from.

“In January, I went to a meeting and met her, and in May, she bought her first bottle – so that was four months from me seeing her to her deciding to buy some. 

“And you know, she had exactly the same experience as me; as soon as she tried it, she was sleeping better, her pain was better, she’s a lot less stressed. And she wrote and told me, ‘You know, I was a cynic, when I saw you that night and I didn’t believe it’.

“So, we can definitely turn people’s opinions around, but we still meet with resistance.”

As for the future, Mike hopes to see more clarity in the industry, giving consumers the ability to make informed choices.

He said: “My vision, as a consumer as well as a seller, is getting to the point where consumer confidence is there, and I don’t think it is at the moment. I think that’s why some CBD businesses struggle, because we need clarity of labelling, we need clarity of what’s in the bottle, backed up with the lab reports on websites – very much like with alcohol, where, if you go and buy a bottle of wine or a bottle of beer, you can tell how much alcohol is in it.

“I think we need to get to that sort of standard whereby a bottle of CBD tells you exactly how much CBD is in there and how much THC is in there, so that people can make that informed purchase.

“If things continue as they are, then we may get to a position where a lot of CBD is synthetic, made by the pharmaceutical companies and that, from a consumer point of view, isn’t possibly the best way forward.

“In the industry, we know that the natural product is the one that works, and that should be what’s being promoted to the consumer.”

Whatever happens within the industry, Mike says Medivita is here to stay: “We’re quite small at the moment, I make no bones about that, but we’ve got plans to grow.

“We’re not in it for the short term, we’re in it for the long run; we’re not just interested in making a quick buck overnight.”

Continue Reading


Could CBD really boost fertility?



Cannabis Health reports on cannabis oil’s rising prominence in the lives of people hoping to start a family.

With data showing that around 1 in 7 couples in the UK struggle to conceive, and alternatives such as IVF proving costly, many couples are keen to try alternative methods to help them on their journey to parenthood – including CBD oil.

While there may not be much official guidance and advice surrounding the correlation between CBD oil use and enhanced fertility, some studies suggest the oil could play a role in increasing fertility in couples who previously struggled to conceive.

This shouldn’t be confused, however, with the intake of Tetrahydrocannabinol (THC) through smoking weed, which is shown to have damaging effects on fertility. Previous studies have shown that smoking cannabis can result in reduced testosterone levels and poor sperm count and mobility, making it much more difficult for men to conceive naturally.

Research into CBD and fertility is emerging, with early studies, plus anecdotal evidence from patients showing a potentially positive link.

Firstly, let’s talk science and hormones. Studies have suggested that CBD oil can play a vital role in hormone balancing for both men and women, aiding in the success of conception.

Researchers at the Paediatrics Department at Vanderbilt University said: “The life of the egg and the beginning of a pregnancy, depends on a healthy endocannabinoid system.”

Elsewhere, in the paper ‘The role of the endocannabinoid system in female reproductive tissues’, researchers state: “While the ECS is known to modulate pain and neurodevelopment, it is also known to impact the female reproductive system.”

Various other papers have also indicated a positive correlation between a balanced ECS and improved fertility, in particular the benefit of a specific amount of the endocannabinoid anandamide.

In women, high levels of anandamide – a type of endocannabinoid found in the body – occur at ovulation and are associated with a successful pregnancy, where low levels or a deficiency can be detrimental.That’s where CBD can begin to have an impact, boosting anandamide levels by preventing its breakdown and supporting successful ovulation.

However, timing is everything for in this relationship. Low levels of anandamide are required during embryo implantation, meaning use of CBD after conception may have a negative interference with the pregnancy.

Cannabinoid receptors have also been found in female ovaries, including granulosa cells or follicles cells of secondary and tertiary follicles.

According to researchers from the University of Naples, Italy: “Cannabinoid and adrenergic systems coordinate together oviductal motility for normal journey of embryos into the uterus.”

Researchers in Canada also found that CBD can have a positive impact at the very start of conception, linking female sexual arousal to activity in the endocannabinoid system.

Meanwhile, research conducted by Dr. Hans Hatt at Ruhr University in Germany has found a link between CBD and the impact on male fertility.

The study found that a receptor (GPR18) previously thought to be part of the ECS is also present in sperm cells, providing a link between cannabinoids, the ECS and fertility.

Evidence suggests CBD may play a key role in an essential biological process for procreation called the acrosome reaction.

When the GPR18 receptor in sperm cells is activated, this acrosome reaction is triggered, altering the sperm slightly to remove the protective ‘cap’ on its head and allowing it to effectively penetrate the egg.

While more research is needed, early indication is that CBD can positively impact the chance of conception in both parties.

Anyone who has had difficulty to conceiving will know that mental health can often have as much of an impact as physical causes.

Stress, anxiety, depression and other mental health conditions can have a hugely negative impact on fertility in both men and women by lowering hormones necessary for egg and sperm production.

Again, this is where CBD can help. It is widely reported this can directly activate serotonin (the ‘happiness chemical’) receptors, helping to boost mood and relax both partners.

CBD has also been found to regulate cortisol secretion, the stress activating hormone. Among other things, stress can also delay ovulation, making it difficult for women to attempt conception at their most fertile.

So, while research and guidance from industry bodies is still emerging, preliminary studies are showing a positive relationship between the use of CBD oil and fertility.

With ever-increasing sales, it seems more and more are opting to try something new on their journey to parenthood.

Continue Reading


From cannabis sceptic to advocate

How Michele Ross, who educates people about the use of medical cannabis, started her life being very much against it.



When Michele Ross was growing up, she lived opposite a crack cocaine house, and saw first-hand the destruction drugs can cause.

“I was very much against drugs, I was passionate about getting people off drugs because I’d seen the impact of what comes with them,” she tells Cannabis Health.

Ross, who appeared on US Big Brother in 2009, knew from an early age that she wanted to work in the fields of medicine and science.

She worked her way up and got a PhD in neuroscience, studying drug addiction. Her first assignment was a paper looking at the role of cannabinoids in growing new brain cells.

Her goal was to write about how cannabis was bad for the brain, but that’s not exactly what she discovered.

“Up until my early twenties, I was taught that cannabis was a very bad drug, it was lumped in with what we’d consider hard drugs,” she says.

She was determined to find out more about cannabis, and moved to California after her PhD to do post-doctoral work, where she was exposed to people using medical cannabis for the first time.

She was working on other areas of research, but she eventually fell into the cannabis industry because of her own health issues.

“I always had pain and fatigue, but it was difficult to get diagnoses for lots of things. I ended up with lead poisoning, blood clots on my lungs, lots of weird things – but no one could figure out what was wrong with me for a while.”

Cannabis was one of the few things that helped what Ross terms clinical endocannabinoid deficiency, which, according to some studies, is a disorder where sufferers have an imbalance in their endocannabinoid system.

“Whether it’s oil or edibles, it doesn’t seem matter what form it is, my body really needs cannabis,” she says.

“I was always in pain, tired, sick – if I have cannabis, my nerves work, I’m happy and not in pain and life is great.”

Ross realised if this discovery could be so drastic for her, it probably would be for others, too.

“As a scientist and a patient, if this works for me, I wondered whether it would work for others.”

This thought led Ross on to write a series of books based on her work.

“It’s exciting to be able to share my passion. I got myself out of a wheelchair and lived a life before all these medical problems happened to me, now I’m able to help others. I should be working in a lab, but I talk to patients instead.”

As well as her books, Ross writes online courses to educate people on taking medical cannabis. She also works for Veriheal, a medical technology company that provides cannabis education.

During the Covid-19, Ross has observed lots of people struggling with increased anxiety from losing their jobs, family members passing away and the general added stresses of the pandemic. Many have been unable to see their doctor.

“Patients come to us to learn about cannabis, a lot have said that if they didn’t have cannabis, they’d be drinking two bottles of wine a night, which we know isn’t safe or healthy.

“I’m glad I can offer services to patients during this time so they can go down a different route.”

And Ross says educating people about the medical benefits of cannabis is a big job, as people have a lot of misconceptions, including not knowing the difference between CBD and THC, which can be psychoactive.

“People don’t know where CBD might work for them and might not be best for others; there are huge differences between stage four cancer patients and people looking for help for their anxiety. People need a lot of hand-holding.”

She educates people on the legal side of medical cannabis, as there are different rules in different US states and cannabis isn’t legal on a federal level.

Ross is among the campaigners pushing for this to change. She’s also pushing for changes to the US banking system, which bans cannabis payments.

“I don’t sell CBD products in my practice, but my book, Vitamin Weed, has been flagged by numerous banks and credit card processing companies, who told me I’m high risk,” Ross says.

“I was stopped at the Canada/US border by the US, who thought I was shiping cannabis. I said this isn’t a code word, it’s a book. They treat my business the same as they would if I was telling people to shoot up heroin.”

Although Ross’s career has taken an untraditional route, she’s glad she has a neuroscience background.

“What excites me is the potential for cannabis to treat so many different neurological symptoms and conditions, including Alzheimer’s, Parkinson’s and traumatic brain injury.

“I’ve been able to focus on brain health and talk to many patients coming from the research angle – the potential to complete revolutionise healthcare is here.”

Ultimately, she hopes to continue using her unique experience as a scientist and a patient to help educate others.

“As a patient with fibromyalgia, I see so many patients who see the stigma and not potential of cannabis,” she says.

“There’s so much miseducation around it, but cannabis has changed my life. I’ve come off 12 medications because of it. We can’t cure my fibromyalgia but, basically, I’m in remission.

“I want to spread that information and help as many people as I can, empowering patients to use medicine in personal way to relieve the multitude of symptoms that come with this disease, which is rooted in endocannabinoid deficiency.

“I believe cannabis should be the first treatment, not the last.”

And as a neuroscientist, she says her title helps.

“My Dr title is really important. It’s nice to be an authority in the field. It also helps when talking to politicians, and other doctors, who really want to listen to someone who has that hard science background.

“It doesn’t matter that I’m a patient and advocate – they see hundreds of patients it as anecdotal evidence. When I can give them a three-hour lecture of the endocannabinoid system, it’s real.”

Continue Reading